Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
To access this article, please choose from the options below
PII: S1538-4721(08)00646-6
doi:10.1016/j.brachy.2008.09.004
© 2009 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
